Clinical trial
Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia…
NCT00398983 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00398983 |
|---|---|
| Title | Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) |
| Official title | Randomized Study of Decitabine Versus Observation or Continued Standard Chemotherapy as Maintenance Therapy for Adults With Unfavorable Risk AML in First Complete Remission (CR) or Adults With Relapsed AML in Second or Greater CR |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia |
| Intervention type | Drug |
| Interventions | Decitabine |
| Enrollment | 50 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2012 |
| Completion | May 1, 2012 |
| First posted | Nov 14, 2006 |
| Last update posted | Mar 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: